Apart from the fact that YAP, being an important downstream effector of ASPP2, could exert some effects on cancer cells that are completely opposite of tumor suppression, frequent mutation of p53 in pancreatic cancer may also explain why lack of ASPP2 did not improve the tumor growth as expected. This evidence concerns the gene TP53BP2 and neoplasm.